ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $296 | – | 10 | -16.7% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 12 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $2,432,000 | -93.1% | 108,950 | -92.3% | 0.01% | -91.5% |
| Q1 2022 | $35,462,000 | -32.5% | 1,412,259 | -3.7% | 0.09% | -22.3% |
| Q4 2021 | $52,554,000 | -15.2% | 1,466,763 | +0.8% | 0.12% | -19.3% |
| Q3 2021 | $61,950,000 | -1.3% | 1,455,593 | +0.4% | 0.15% | -3.2% |
| Q2 2021 | $62,746,000 | +26.0% | 1,449,442 | +18.7% | 0.16% | +15.7% |
| Q1 2021 | $49,814,000 | -28.8% | 1,221,241 | -21.0% | 0.13% | -33.7% |
| Q4 2020 | $69,984,000 | +32.6% | 1,546,260 | +3.7% | 0.20% | +5.8% |
| Q3 2020 | $52,788,000 | +1.3% | 1,491,610 | +6.7% | 0.19% | -12.0% |
| Q2 2020 | $52,106,000 | +35.8% | 1,397,783 | +5.3% | 0.22% | -0.9% |
| Q1 2020 | $38,375,000 | -44.5% | 1,327,397 | -0.5% | 0.22% | -34.4% |
| Q4 2019 | $69,193,000 | -6.2% | 1,334,479 | -0.7% | 0.33% | -13.2% |
| Q3 2019 | $73,782,000 | +11.6% | 1,344,190 | -17.4% | 0.38% | +10.3% |
| Q2 2019 | $66,114,000 | +37.2% | 1,627,634 | +2.2% | 0.35% | +26.9% |
| Q1 2019 | $48,182,000 | +1.1% | 1,593,321 | +12.3% | 0.28% | -16.4% |
| Q4 2018 | $47,679,000 | -27.0% | 1,418,605 | -8.4% | 0.33% | -13.9% |
| Q3 2018 | $65,316,000 | +27.6% | 1,548,516 | -3.2% | 0.38% | +16.5% |
| Q2 2018 | $51,206,000 | -39.7% | 1,600,173 | -6.3% | 0.33% | -48.3% |
| Q1 2018 | $84,888,000 | -5.6% | 1,707,325 | +2.4% | 0.64% | -12.9% |
| Q4 2017 | $89,880,000 | -6.5% | 1,667,210 | +0.6% | 0.73% | -15.9% |
| Q3 2017 | $96,101,000 | +36.8% | 1,656,918 | +16.4% | 0.87% | +23.7% |
| Q2 2017 | $70,241,000 | +21.1% | 1,423,593 | +6.6% | 0.70% | +10.9% |
| Q1 2017 | $58,000,000 | +86.6% | 1,335,175 | +110.3% | 0.63% | +70.4% |
| Q4 2016 | $31,086,000 | +124.6% | 634,941 | +119.5% | 0.37% | +114.5% |
| Q3 2016 | $13,841,000 | -14.1% | 289,266 | -3.7% | 0.17% | -28.8% |
| Q2 2016 | $16,108,000 | +25.9% | 300,247 | +4.9% | 0.24% | +16.8% |
| Q1 2016 | $12,797,000 | +0.5% | 286,150 | -14.2% | 0.21% | -1.0% |
| Q4 2015 | $12,728,000 | +17.3% | 333,538 | -2.2% | 0.21% | +14.1% |
| Q3 2015 | $10,854,000 | – | 340,991 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |